MiR-7-5p targeted Rb regulating cell cycle is involved in hydroquinone-induced malignant progression in human lymphoblastoid TK6 cells

被引:0
作者
Zhai, Lu [1 ]
Gao, Yuting [1 ]
Cui, Zheming [1 ]
Chen, Lin [1 ]
Yu, Lingxue [1 ]
Guo, Pu [1 ]
Zhu, Delong [1 ]
Tang, Huanwen [1 ,2 ]
Liu, Xin [1 ]
Luo, Hao [1 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Dongguan Key Lab Environm Med, Dongguan, Peoples R China
[2] Guangdong Med Univ, Dongguan Affiliated Hosp 1, Dongguan, Peoples R China
基金
中国国家自然科学基金;
关键词
Hydroquinone; miR-7-5p; Cell cycle; Rb; TUMOR-SUPPRESSOR; PROLIFERATION; APOPTOSIS; LEUKEMIA; BENZENE; DISEASE;
D O I
10.1016/j.fct.2023.114186
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
MiR-7-5p has been demonstrated to inhibit tumorigenesis by limiting tumor cell proliferation, migration and invasion. However, its role in countering hydroquinone (HQ)-induced malignant phenotype of TK6 cells has remained unclear. The present study aimed to investigate whether miR-7-5p overexpression could restrain the malignant phenotype in TK6 cells exposed to HQ. The results displayed that HQ suppressed the expression of miR-7-5p and promoted cell cycle progression. Further investigations confirmed that miR-7-5p could decelerate the cell cycle progression by targeting Rb after acute HQ exposure. Through the regulation of the Rb/E2F1 signaling pathway, the overexpression of miR-7-5p mitigated HQ-induced malignant phenotype in TK6 cells by impeding cell cycle progression. In conclusion, miR-7-5p overexpression appears to be involved in HQ-induced malignant transformation by suppressing Rb/E2F1 signaling pathway, resulting in a deceleration of the cell cycle progression.
引用
收藏
页数:8
相关论文
共 22 条
[1]   The Role of RB in Prostate Cancer Progression [J].
Burkhart, Deborah L. ;
Morel, Katherine L. ;
Sheahan, Anjali V. ;
Richards, Zachary A. ;
Ellis, Leigh .
PROSTATE CANCER: CELLULAR AND GENETIC MECHANISMS OF DISEASE DEVELOPMENT AND PROGRESSION, 2ND EDITION, 2019, 1210 :301-318
[2]   Hydroquinone-induced malignant transformation of TK6 cells by facilitating SIRT1-mediated p53 degradation and up-regulating KRAS [J].
Chen, Yuting ;
Chen, Jiajia ;
Yun, Lin ;
Xu, Longmei ;
Liu, Jiaxian ;
Xu, Yongchun ;
Yang, Hui ;
Liang, Hairong ;
Tang, Huanwen .
TOXICOLOGY LETTERS, 2016, 259 :133-142
[3]   RB1: a prototype tumor suppressor and an enigma [J].
Dyson, Nicholas J. .
GENES & DEVELOPMENT, 2016, 30 (13) :1492-1502
[4]   RB and cell cycle progression [J].
Giacinti, C. ;
Giordano, A. .
ONCOGENE, 2006, 25 (38) :5220-5227
[5]   Risk of myeloproliferative disease and chronic myeloid leukaemia following exposure to low-level benzene in a nested case-control study of petroleum workers [J].
Glass, Deborah C. ;
Schnatter, A. Robert ;
Tang, Gong ;
Irons, Richard D. ;
Rushton, Lesley .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 71 (04) :266-274
[6]   MicroRNA-7: A miRNA with expanding roles in development and disease [J].
Horsham, Jessica L. ;
Ganda, Clarissa ;
Kalinowski, Felicity C. ;
Brown, Rikki A. M. ;
Epis, Michael R. ;
Leedman, Peter J. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 69 :215-224
[7]   Schistosoma japonicum MiRNA-7-5p Inhibits the Growth and Migration of Hepatoma Cells via Cross-Species Regulation of S-Phase Kinase-Associated Protein 2 [J].
Hu, Chao ;
Zhu, Shanli ;
Wang, Jing ;
Lin, Yu ;
Ma, Li ;
Zhu, Liufang ;
Jiang, Pengyue ;
Li, Zhengli ;
Pan, Weiqing .
FRONTIERS IN ONCOLOGY, 2019, 9
[8]   The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy [J].
Hutcheson, Jack ;
Witkiewicz, Agnieszka K. ;
Knudsen, Erik S. .
CELL CYCLE, 2015, 14 (24) :3812-3819
[9]  
Jiang DF, 2022, J NANOBIOTECHNOL, V20, DOI 10.1186/s12951-021-01206-7
[10]   The broken cycle: E2F dysfunction in cancer [J].
Kent, Lindsey N. ;
Leone, Gustavo .
NATURE REVIEWS CANCER, 2019, 19 (06) :326-338